Vemurafenib-induced toxic epidermal necrolysis: Is it an emerging side-effect of the drug?
J Eur Acad Dermatol Venereol
.
2017 Aug;31(8):e354-e355.
doi: 10.1111/jdv.14150.
Epub 2017 Feb 21.
Authors
S Kılıç
1
,
E Özkaya
1
,
C Baykal
1
,
S Vatansever
2
Affiliations
1
Department of Dermatology and Venereology, Istanbul Medical Faculty, Istanbul University, 34093, Çapa-Istanbul, Turkey.
2
Department of Medical Oncology, Institute of Oncology, Istanbul University, 34093, Çapa-Istanbul, Turkey.
PMID:
28150343
DOI:
10.1111/jdv.14150
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Aged
Antineoplastic Agents / adverse effects*
Fatal Outcome
Humans
Male
Stevens-Johnson Syndrome / etiology*
Vemurafenib / adverse effects*
Substances
Antineoplastic Agents
Vemurafenib